Eric Brown Study Uncovers 4-Molecule Antibiotic Megacluster Against Superbugs

2 articles · Updated · Ars Technica · Jun 26

A Nature study led by McMaster University researcher Eric Brown identified a gene “megacluster” that encodes four molecules acting together against one essential bacterial metabolic pathway.
That multi-molecule design points to a new antibiotic strategy because most current drugs rely on a single bioactive molecule, which bacteria can sometimes defeat with a single mutation.
More than 80% of antibiotics used in clinics today are derived from microbial “natural products,” but discoveries of new ones have slowed sharply as resistance has climbed.
The finding offers a potential new regimen and a broader blueprint for staying ahead in the long-running microbial arms race that has eroded the effectiveness of existing antibiotics.

Sources

Ars Technica3h ago

Eric Brown's Study Discovers Antibiotic Megacluster, Offers New Superbug Strategy

Drug Target Review8h ago

Streptomyces antibiotic 'megacluster' targets biotin to combat drug-resistant infections | Drug Target Review

With new drugs taking over a decade to develop, can this discovery win the race against rapidly evolving superbugs?

This natural antibiotic kills invaders, but what collateral damage might it inflict on our essential human microbiome?

Is this four-molecule 'super-weapon' truly resistance-proof, or just a more complex lock for bacteria to inevitably pick?

Landmark Discovery: Streptomyces Megacluster Yields Four Biotin-Targeting Antibiotics to Fight Drug-Resistant Bacteria

Overview

In 2026, researchers at McMaster University led by Eric Brown made a major breakthrough against antibiotic resistance by discovering a megacluster of genes in Streptomyces bacteria. This cluster produces four new antibiotics that work together, making them more effective than any single drug. These antibiotics target the biotin pathway, which is essential for bacterial survival, offering a promising way to fight even multidrug-resistant bacteria like E. coli. By disrupting this vital process, the discovery opens new possibilities for overcoming resistance and adds powerful tools to our shrinking antibiotic arsenal.

...